English 
Español 
français 
العربية Search
Search
Capecitabine is mainly used to treat non-small cell lung cancer, pancreatic cancer, bladder cancer, breast cancer and other solid tumors.
Capecitabine is an antimetabolic fluoropyrimidine deoxynucleoside carbamate that can be converted to 5-FU in vivo, can inhibit cell division and interfere with RNA and protein synthesis, and is suitable for further treatment of paclitaxel and advanced primary or metastatic breast cancer that does not respond to anthracycline chemotherapy regimens, mainly for the treatment of advanced primary or metastatic breast cancer, rectal, colon and gastric cancer.
| Items | Specifications | Results |
| Appearance | White to off-white powder | White powder |
| Individual unspecified impurity | ≤0.1% | 0.031% |
| Total unspecified impurities | ≤0.5% | 0.07% |
| Total impurities | ≤1.5% | 0.20% |
| Water | ≤0.3% | 0.04% |
| Residue on ignition | ≤0.1% | Conforms |
| Assay | 98.0%~102.0% | 99.60% |
| Product parameters | |
| Cas number: | 154361-50-9 |
| Appearance: | White to off-white powder |
| Purity: | 98~102% |
| Package details: | 1kg/foil bag; 25kg/fiber drum |
| Brand: | Fortunachem |
An antineoplastic agent. A prodrug of doxifluridine.
Fortunachem Provides Not Only Professional Chemical Products But Also Professional Help
Keeping you up-to-date with all the latest information, news, and events about Fortunachem!
Quick Links
Add:
E-mail:
